Eyebright Medical Technology Beijing Co Ltd (688050) — Capital Reinvestment Ratio
Eyebright Medical Technology Beijing Co Ltd (688050) has a Capital Reinvestment Ratio of 0.28x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥76.92 Million) in capital expenditures (CN¥21.37 Million). See net asset quality index of Eyebright Medical Technology Beijing Co to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Eyebright Medical Technology Beijing Co Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks Eyebright Medical Technology Beijing Co Ltd's Capital Reinvestment Ratio across 9 annual periods. Check Eyebright Medical Technology Beijing Co investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Eyebright Medical Technology Beijing Co Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for Eyebright Medical Technology Beijing Co Ltd from 2017 to 2025. For live market cap and broader valuation context, see 688050 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | CN¥369.15 Million | CN¥123.14 Million | ▼ -64.8% |
| 2024 | 0.95x | CN¥347.75 Million | CN¥329.48 Million | ▼ -42.1% |
| 2023 | 1.64x | CN¥226.27 Million | CN¥370.34 Million | ▲ +51.1% |
| 2022 | 1.08x | CN¥250.13 Million | CN¥271.03 Million | ▼ -23.6% |
| 2021 | 1.42x | CN¥219.30 Million | CN¥311.22 Million | ▲ +47.4% |
| 2020 | 0.96x | CN¥123.35 Million | CN¥118.73 Million | ▼ -65.7% |
| 2019 | 2.80x | CN¥50.49 Million | CN¥141.61 Million | ▲ +24.3% |
| 2018 | 2.26x | CN¥31.82 Million | CN¥71.81 Million | ▼ -70.3% |
| 2017 | 7.60x | CN¥4.15 Million | CN¥31.53 Million | — |